Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.75 |
| ▸ | NR4A2 | P43354 | 5/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.56 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.56 |
| ▸ | NR4A1 | P22736 | 2/20 | 0.55 |
| ▸ | NR4A3 | Q92570 | 2/20 | 0.55 |
| ▸ | GCK | P35557 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.53 |
| ▸ | RELA | Q04206 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.53 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3488958 | 0.97 | MEN1 (0.75) | MEN1KMT2ANR4A2KDM4ENPC1 | |
| SCHEMBL7597018 | 0.93 | MEN1 (0.77) | MEN1KMT2ANR4A2KDM4ENPC1 | |
| SCHEMBL9167771 | 0.88 | PLA2G2A (0.76) | MEN1KMT2ANR4A2PLA2G2ANR4A1 | |
| SCHEMBL9323885 | 0.87 | MEN1 (0.82) | MEN1KMT2ANR4A2MRGPRX4NR4A1 | |
| SCHEMBL1426961 | 0.87 | MEN1 (1.00) | MEN1KMT2ANR4A2MRGPRX4NR4A1 | |
| SCHEMBL2808656 | 0.86 | LMNA (0.59) | MEN1KMT2ANR4A2KDM4ENPC1 | |
| SCHEMBL3488635 | 0.86 | MEN1 (0.58) | MEN1KMT2ANR4A2KDM4ENPC1 | |
| SCHEMBL2651146 | 0.86 | KMT2A (0.79) | MEN1KMT2ANR4A2PLA2G2AMRGPRX4 | |
| SCHEMBL29788233 | 0.85 | MEN1 (0.84) | MEN1KMT2ANR4A2NPC1MRGPRX4 | |
| SCHEMBL340452 | 0.85 | MEN1 (0.84) | MEN1KMT2ANR4A2NPC1MRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7943607-B2 | Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes | ASTRAZENECA AB (SE) | 2011-05-17 | — | — | US | disclosed |
| US-20090105214-A1 | Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes | ASTRAZENECA AB (SE) | 2009-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090105214-A1 | Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes | GCK, GCKR, GK | MEN1 3245/4885KMT2A 2218/4885NR4A2 637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.